Altimmune, Inc. (ALT)
4.02
-0.06
(-1.47%)
USD |
NASDAQ |
Jan 09, 16:00
4.06
+0.04
(+1.00%)
After-Hours: 20:00
Altimmune Gross Profit (Annual): -0.218M for Dec. 31, 2024
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Viking Therapeutics, Inc. | -0.346M |
| CorMedix, Inc. | 40.28M |
| Seres Therapeutics, Inc. | -14.70M |
| Rhythm Pharmaceuticals, Inc. | 116.05M |
| Terns Pharmaceuticals, Inc. | -0.896M |